The Valley Desk

ArticleClinical lung cancerPublished

Outcomes Following First-Line Immune Checkpoint Inhibitors With or Without Chemotherapy Stratified by KRAS Mutational Status-A Real-World Analysis in Patients With Advanced NSCLC

Read the publication ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Clinical lung cancer
Published
Subject terms
Humans; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Prognosis; Survival Rate; Retrospective Studies; Follow-Up Studies; Mutation; Adult; Aged; Aged, 80 and over
PubMed ID
40544018
Added to directory
Source checked

Report a correction or request removal